RC
IDXX icon

Rexford Capital’s Idexx Laboratories IDXX Stock Holding History

Rexford Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171K Hold
305
– – 0.12% 181
2025
Q4 		$206K Hold
305
– – 0.16% 161
2025
Q3 		$195K Hold
305
– – 0.15% 167
2025
Q2 		$164K Buy
+305
New +$146K 0.14% 179

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Rexford Capital's IDXX Position: Q1 2026 in Review

Rexford Capital held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 305 shares worth $171K. The position accounts for 0.12% of the portfolio, ranked #181.

Rexford Capital first reported a position in IDXX in Q2 2025 and has held it in 4 quarters since. The position peaked at $206K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Rexford Capital held 305 shares of Idexx Laboratories worth $171K as of Q1 2026.
  • Rexford Capital left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.12% of Rexford Capital's portfolio in Q1 2026, its #181 holding.
  • Rexford Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 4 quarters since.
  • Rexford Capital's Idexx Laboratories position peaked at $206K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Rexford Capital's 13F filing for Q1 2026, filed 24 Apr 2026.